Incyte
INCY · NASDAQ
Bulios Fair Price
$124.19
0.2% upside
Trenutna cena
$123.89
Po podatkih Bulios Fair Price se delnica INCY trenutno trguje blizu svoje poštene vrednosti. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
AI poročilo o poslu, financah, vrednotenju, razpoloženju, novicah in tveganjih - napisano v nekaj minutah.
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
O podjetju
Incyte Corporation (INCY) is an American biopharmaceutical company specializing in the research, development, and commercialization of therapies focused on oncology and other serious diseases. The company is known for its strong emphasis on scientific research and innovation, leading to the discovery of new therapeutic possibilities. Incyte focuses on developing small molecule drugs and immunotherapies that have the potential to significantly improve patients' lives. Incyte Corporation (INCY) shares might be appealing to investors seeking involvement in the biotechnology sector with a focus on innovation and treatment of serious diseases.
V vašem jeziku še ni na voljo, zato je besedilo v angleščini.
Sector
Healthcare
Industry
Biotechnology
CEO
William J. Meury
Employees
2,844
Headquarters
Wilmington
Prihajajoči dogodki
Earnings
Upcoming earnings report